TRPM4 inhibition promotes angiogenesis after ischemic stroke

Area of Science:

• Neuroscience
• Vascular Biology
• Molecular Biology

Background:

• Transient receptor potential melastatin 4 (TRPM4) is a cation channel implicated in cell death under pathological conditions.
• TRPM4 channel activity is linked to cellular integrity and survival.

Purpose of the Study:

• To investigate the role of TRPM4 in the vascular endothelium following hypoxia/ischemia.
• To evaluate TRPM4 as a potential therapeutic target for ischemic stroke.

Main Methods:

• Studied TRPM4 expression in human umbilical vein endothelial cells (HUVECs) after oxygen-glucose deprivation.
• Utilized 9-phenanthrol to block TRPM4 in vitro.
• Administered siRNA targeting TRPM4 in a rat middle cerebral artery occlusion (MCAO) stroke model.
• Assessed angiogenesis, capillary integrity, infarct volume, and motor function recovery.

Main Results:

• TRPM4 expression increased in HUVECs and rat brain vasculature post-hypoxia/ischemia and MCAO.
• TRPM4 inhibition enhanced endothelial tube formation in vitro.
• TRPM4 silencing in vivo improved angiogenesis, capillary integrity, reduced infarct volume, and improved motor function.
• The protective effects of TRPM4 suppression were most significant during the acute phase post-stroke.

Conclusions:

• TRPM4 is upregulated in the vascular endothelium during acute ischemic stroke.
• TRPM4 plays a critical role in cerebral damage in the early stages of stroke.
• Targeting TRPM4 presents a promising therapeutic strategy for acute ischemic stroke.